Diagnostic-Therapeutic Cascade Revisited
- 16 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 118 (25) , 2797-2802
- https://doi.org/10.1161/circulationaha.108.789446
Abstract
Background— There is wide geographic variation in the use of coronary revascularization in the United States. Rates are closely related to rates of coronary angiography. We assessed the relationship between coronary angiography and coronary artery revascularization by procedure type (coronary artery bypass graft surgery or percutaneous coronary intervention). Methods and Results— Using Part B claims for a 20% sample of the Medicare population, we calculated population-based rates of testing and treatment by region, using events identified in Part B claims as the numerator and the total number of Medicare beneficiaries residing in the area as the denominator and adjusting for regional differences in demographic characteristics with the indirect method. Cardiac catheterization rates varied substantially across regions, from 16 to 77 per 1000 Medicare beneficiaries. The relationship between coronary angiography rates and total coronary revascularization rates was strong ( R 2 =0.84). However, there was only a modest association between coronary angiography rates and coronary artery bypass graft surgery rates ( R 2 =0.41) with the suggestion of a threshold effect. The association between coronary angiography rates and percutaneous coronary intervention rates was strong ( R 2 =0.78) and linear. Conclusions— The diagnostic-therapeutic cascade for coronary artery disease differs by therapeutic intervention. For coronary artery bypass graft surgery, the relationship is modest, and there appears to be a testing threshold beyond which additional tests do not result in additional surgeries. For percutaneous coronary intervention, the relationship is very tight, and no threshold appears to exist. Given the results of recent studies of medical versus invasive management of stable coronary disease, patients living in high-diagnostic-intensity regions may be getting more treatment than they want or need.Keywords
This publication has 26 references indexed in Scilit:
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionCirculation, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Coronary Intervention for Persistent Occlusion after Myocardial InfarctionNew England Journal of Medicine, 2006
- Bidirectional Ventricular Tachycardia Caused by Digitalis ToxicityCirculation, 2006
- Temporal Trends in the Utilization of Diagnostic Testing and Treatments for Cardiovascular Disease in the United States, 1993–2001Circulation, 2006
- ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2005
- Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery DiseaseCirculation, 2005
- ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary ArticleCirculation, 2004
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)Journal of the American College of Cardiology, 1999